Gangnam Severance Hospital
SIRT therapy in the Republic of Korea typically costs from AUD $20,848 to AUD $30,913. Expenses depend on hospital tier, preliminary imaging, and the specific isotope dose required. Australians save approximately 27% compared to local private costs of AUD $35,657. Pricing usually covers the procedure, initial consultations, and a short hospital stay in Seoul.
Bookimed Expert Insight: Choosing a Seoul-based multidisciplinary centre offers Australians superior value and safety. Gangnam Severance Hospital, founded in 1885, provides access to 39 specialised departments. It holds Joint Commission International (JCI) accreditation, a global gold standard for clinical quality. This ensures strict safety systems are in place for complex radiative procedures like SIRT. While university hospitals in the capital may carry a price premium, their accreditation from bodies like JCI justifies the investment for complex cancer care.
| Republic of Korea | Thailand | Turkey | |
| SIRT therapy | from AUD $20,848 | from AUD $28,756 | from AUD $34,507 |
No hidden fees – just official clinic prices. Pay at the clinic for SIRT therapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in SIRT therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your SIRT therapy journey.
Candidates for SIRT in South Korea are patients with unresectable liver tumours or liver-dominant metastases. Eligible individuals must have well-preserved liver function and a WHO/ECOG performance status of 0–1. Specialists at JCI-accredited centres like Gangnam Severance Hospital use SIRT. It treats primary hepatocellular carcinoma and metastatic colorectal cancer.
Bookimed Expert Insight: Many Australian patients seek SIRT for primary cancer. South Korean centres, however, frequently use it for downstaging. This process shrinks tumours to make surgical removal possible. Facilities like Gangnam Severance Hospital often combine this with Tomotherapy for comprehensive radiation targeting.
Patient Consensus: Patients with liver-dominant disease found the mapping procedure in South Korea essential. It provided peace of mind. Many noted that specialists there provided very clear eligibility criteria. These covered tumour size and liver function.
SIRT therapy for liver cancer in South Korea achieves an objective response rate of approximately 54.6%. This is based on clinical data. This treatment, also known as Y-90 radioembolisation, offers a median overall survival of nearly 24 months. This applies to advanced hepatocellular carcinoma patients treated at JCI-accredited Seoul facilities.
Bookimed Expert Insight: South Korea is a global oncology hub. However, SIRT therapy is concentrated in premier Seoul institutions like Gangnam Severance Hospital. This facility utilises dual Tomotherapy devices and AI-integrated systems. These help radiation target tumours accurately while sparing healthy liver tissue. This level of precision is why intermediate-stage patients see such high stability rates.
Patient Consensus: Patients find that South Korean specialists provide highly detailed data from accredited medical databases. Consultations often include verified oncology board publications. This helps Australians feel confident in the clinical evidence.
SIRT therapy in South Korea typically causes mild side effects like fatigue, abdominal pain, and nausea, collectively called post-embolisation syndrome. These generally resolve within a week. Specialists at JCI-accredited centres like Gangnam Severance Hospital use precise mapping. This helps prevent rare complications like radiation hepatitis or gastritis.
Bookimed Expert Insight: Leading Seoul clinics combine SIRT with high-end imaging like Tomotherapy to track radiation delivery. Gangnam Severance Hospital has been at the forefront of medical technology in Asia since 1885. This long-standing experience helps their oncology teams achieve high precision while managing patient comfort.
Patient Consensus: Patients often mention feeling tired but find the recovery manageable with standard medications. Those visiting Republic of Korea appreciate having English-language guides. They also value clear communication about their recovery steps.
SIRT is a targeted radiation treatment used for inoperable liver tumours in South Korean hospitals. Specialists inject millions of tiny radioactive Yttrium-90 microspheres into the hepatic artery. These beads lodge in tumour vessels. They deliver high-dose radiation directly to the cancer while sparing healthy liver tissue.
Bookimed Expert Insight: South Korean oncology centres frequently integrate SIRT with local therapies like stentings or robotic surgery. This multidisciplinary approach is common at JCI-accredited facilities in Seoul. Gangnam Severance Hospital, for example, combines imaging and multidisciplinary expertise to manage complex liver cases.
SIRT therapy recovery in South Korea is swift. Most patients return home within 1 to 2 days. This internal radiation treatment allows for faster discharge than traditional surgery. Initial side effects typically fade within 7 days, though fatigue can last up to 3 weeks.
Bookimed Expert Insight: JCI-accredited facilities in Seoul combine SIRT with imaging like Tomotherapy. Gangnam Severance Hospital is one example. This approach often results in shorter hospital stays than the global average. Patients spending over A$6,800 often receive free airport transfers and interpreter services.
Gangnam Severance Hospital in Seoul is a leading choice for SIRT treatment in South Korea. This JCI-accredited facility specialises in oncology using a multidisciplinary approach. Surgeons there utilise technologies like Tomotherapy and the da Vinci robotic system. This allows them to treat complex liver tumours with high precision.
Bookimed Expert Insight: SIRT in South Korea costs from $14,500 to $21,500. This represents a significant saving of 27%. This is compared to the $24,800 Australian average for the same radioembolisation therapy. These savings often cover the entire travel budget for Seoul.
Patient Consensus: Patients recommend verifying if a clinic refers to SIRT as TARE or radioembolisation. Many find the international departments at major Seoul hospitals make coordinating complex oncology care straightforward.